Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 3611-3620 Newer>

The Motley Fool September 21, 2004 Rick Aristotle Munarriz	Why Napster Rocks Roxio's Napster and RealNetworks' Rhapsody will make both of those companies tempting acquisition targets. As long as each stock remains depressed, one -- if not both -- may wind up as buyout bait over the next year.
BusinessWeek September 27, 2004 Nanette Byrnes	Not So Fast, Lord Black Investor Chris Browne's three years of persistence finally brought an answer to his question -- and put an unwanted spotlight on Hollinger Int'l CEO, Conrad Black.
BusinessWeek September 27, 2004 Jim Kerstetter	Peoplesoft: Ease the Inevitable Fighting Oracle's takeover bid made sense at first. Not anymore. Oracle's bid has plenty of upside for the company, and for investors, too.
The Motley Fool September 20, 2004 Seth Jayson	Jersey Junk Bill Debate on a New Jersey junk food bill provides a glimpse of a battle likely to be fought in many capitals and boardrooms. While this could shape up to be an ugly-looking fight, shareholders probably don't have much to fear here.
The Motley Fool September 20, 2004 Jeff Hwang	InterActive and the Permanent Tax Investors should take value into serious consideration before making any investment decision. Also relevant to this situation is that an investor is also playing with a disadvantage when purchasing companies that can't be understood.
The Motley Fool September 20, 2004 Alyce Lomax	Not So Brillian Sears dumps the company as maker of its Veos projection TV. Shares of Brillian recently plunged 36% to their lowest point since the company was spun off in 2003.
The Motley Fool September 20, 2004 Kelvin Taylor	The Windfall of Hurricanes Retailers like Lowe's and Home Depot are benefiting from the rash of hurricanes. The stocks of all these companies have done well over the past few weeks.
The Motley Fool September 20, 2004 Phil Wohl	CarMax Stalls Out The leading car retailer struggles through a difficult operating period. Shares appear to be fairly valued, but perhaps not as solid in the not too distant future.
The Motley Fool September 20, 2004 W.D. Crotty	Does This Biotech Belong in Bargain Bin? Maxim Pharmaceutical's Ceplene produces disappointing results. Stocks are down more than 50%.
The Motley Fool September 20, 2004 Nathan Slaughter	Colgate-Palmolive Washed Away The consumer products firm issues a profit warning for the second half. Investors reacted harshly to the dim forecast, driving the stock 10% lower to a multiyear low of $48.38.
<Older 3611-3620 Newer> Return to current articles.